Nearly nine in 10 general and acute beds at Northumbria Healthcare were occupied in the last week of December, as flu cases increased.
Trametinib, a mitogen-activated protein kinase (MEK) inhibitor, reduces mortality and morbidity in children with severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback